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Abstract
Introduction: The transtelephonic electrocardiogram has been shown to have a great value in the management of out-
of-hospital chest pain emergencies. In our previous study it not only improved the pre-hospital medical therapy and time
to intervention, but also the in-hospital mortality in ST-segment elevation myocardial infarction. It was hypothesised that
the higher in-hospital survival rate could be due to improved transtelephonic electrocardiogram-based pre-hospital
management (electrocardiogram interpretation and teleconsultation) and consequently, better coronary perfusion of
patients at the time of hospital admission. To test this hypothesis, our database of ST-segment elevation myocardial
infarction patients was evaluated retrospectively for predictors (including transtelephonic electrocardiogram) that may
influence in-hospital survival.
Methods and results: The ST-segment elevation myocardial infarction patients were divided into two groups, namely
(a) hospital death patients (n¼ 49) and (b) hospital survivors (control, n¼ 726). Regarding pre-hospital medical man-
agement, the transtelephonic electrocardiogram-based triage (odds ratio 0.48, confidence interval 0.25–0.92,
p¼ 0.0261) and the administration of optimal pre-hospital medical therapy (acetylsalicylic acid and/or clopidogrel and
glycoprotein IIb/IIIa inhibitor) were the most important independent predictors for a decreased risk in our model. At
the same time, age, acute heart failure (Killip class >2), successful pre-hospital resuscitation and total occlusion of the
infarct-related coronary artery before percutaneous coronary intervention were the most important independent
predictors for an increased risk of in-hospital mortality.
Discussion: In ST-segment elevation myocardial infarction patients, (a) an early transtelephonic electrocardiogram-
based teleconsultation and triage, (b) optimal pre-hospital antithrombotic medical therapy and (c) the patency and better
perfusion of the infarct-related coronary artery on hospital admission are important predictors of a lower in-hospital
mortality rate.
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Introduction
Ischaemic heart disease is one of the leading causes of
death worldwide. In the case of ST-segment elevation
myocardial infarction (STEMI), mortality in the first six
months may exceed 10%.1 In the case of STEMI, an early
diagnosis and the prevention of any delay are critical for
an improved outcome. The earlier the treatment, the
greater the benefit, i.e. ‘time is muscle’. In the majority
of STEMI cases the first medical contact takes place out-
side the hospital setting, usually by the paramedic staff.2
This is why the primary, pre-hospital diagnosis of STEMI
and the initiated therapy are generally based on the typical
signs/symptoms of the disease and especially on the elec-
trocardiogram (ECG), as biomarker measurements are
usually not readily available. Besides the traditional pre-
hospital 12-lead ECG, the transtelephonic ECG
(TTECG) can also be used by the paramedics. This
system has already been shown to be of beneficial value
in the diagnosis of ischemic heart disease and in the man-
agement of out-of-hospital chest pain emergencies.2 In our
previous study, we demonstrated that the utilization of
TTECG and TTECG-based consultation between para-
medics and specialists has significantly improved: (a) pre-
hospital medical therapy, (b) time-to-percutaneous
coronary intervention (PCI) and (c) in-hospital mortality
in a large patient cohort (n¼ 775) with STEMI.3 Then we
hypothesised that the higher in-hospital survival rate
could be due, at least in part, to a TTECG-based early
diagnosis that significantly improves pre-hospital medical
therapy and results in better coronary artery perfusion of
patients at the time of hospital admission.3
To test this hypothesis, we decided to retrospectively
evaluate our database of STEMI patients (n¼ 775) for:
(a) TTECG procedures, (b) demographic factors,
comorbidities and cardiac risk factors, (c) pre-
hospital medical therapy and (d) coronary artery
patency and flow before primary PCI. In particular,
we chose to determine the various predictors among
pre-hospital management data (including TTECG)
and PCI procedural findings that may influence the
in-hospital survival of patients. Our objective was to
investigate the difference between the hospital death
group and hospital survival group (control) in an antic-
ipation that an early TTECG and the TTECG-based
pre-hospital therapy of the STEMI patients would
translate into better coronary flow on hospital admis-
sion and improved chance of patient survival.
Methods
Data collection
Patient selection and TTECG methodology were pre-
viously described in detail.3 The STEMI patients were
divided into two groups, namely (a) hospital death
patients at day 20 (n¼ 49) and (b) hospital survivors
(control, n¼ 726). TTECG was done with a battery-
operated, 12-lead, portable system (HeartView P12/
8 Plus by Aerotel). The data transmission was carried
out via the radiotelephone system of the Hungarian
National Ambulance Service (Tetra). The decision to
obtain TTECG was based on the discretion of the
paramedic group. Some teams obtained and trans-
ferred TTECG from all patients and other teams
made it only if they had problems with the clinical
diagnosis and/or with the interpretation of the ECG.3
TTECG was used more frequently by the paramedics if
the scene of the patients was more distant from the PCI
centre (rural areas). After transmitting the ECG signal
to the PCI centre, all important clinical data of the
patient (including the ECG findings and possible pre-
hospital medical therapy) and the patient’s transport
have been discussed in a short teleconsultation.
Acute heart failure (AHF) was defined as a Killip
class >2 during the pre-hospital period. Coronary angi-
ography investigations were performed by a Philips
Integris CV device, and cine loops were recorded at
15 frames/s using 300 mg iodine/ml non-ionic contrast
material. During the examination, intracoronary
nitrate of 200 mg was administered to provide full vaso-
dilatation. The primary PCI procedure was performed
in the standard way.
The patency of the infarct-related artery
(Thrombolysis in Myocardial Infarction (TIMI)
grade) during catheterisation was visually assessed
pre-PCI (during the first coronary angiogram of the
culprit vessel). The criteria used for the assignment of
the TIMI grade were previously described.4 Door-to-
sheath insertion and door-to-balloon times were
defined as the time difference between the arrival of
the ambulance service unit at the PCI centre and the
sheath or balloon insertion in the catheterisa-
tion laboratory.
Data collection for the study was carried out with
the written approval of the patients. Data handling and
collection was approved by the institutional review
boards of the Department of Cardiology, University
of Debrecen, Hungary and the Hungarian National
Ambulance Service.
Statistical analysis
A statistical analysis was carried out using the GB-Stat
v8.0 program. Depending on the type of variable (qual-
itative or quantitative parameter), the descriptive meth-
ods applied involved the calculation of absolute and
relative frequencies, or calculation of the mean and
standard deviation (SD). Normally distributed contin-
uous variables were compared using Student’s t test at
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an a-level of 5%. Categorical variables (baseline
parameters, clinical events and medication) were com-
pared by means of the Wilcoxon rank-sum test at an
a-level of 5%.
Variables with significant differences (p< 0.05)
between groups (hospital death group and control
group) were assessed by applying univariate logistic
regression model and quantified for odds ratios and
95% confidence intervals (CIs). For multiple regres-
sion, cogent predictors of mortality displaying a p
value of <0.05 in univariate analysis were selected
and analysed. For accurate risk assessment, the
number of variables in the multiple regression model
was limited. Also, a p value of <0.05 was considered to
be significant. For the cumulative survival analysis, the
Cox regression model (conditional logistic regression)
was applied.
Results
Altogether, 775 STEMI patients were involved in the
study (49 patients in the hospital death group and 726
patients in the control group). The total in-hospital
mortality on day 20 was 6.32% (49 patients). The fre-
quency of deaths was highest at the beginning of hos-
pitalization (24 deaths occurred on day 1). After day 20
there was no hospital death in this patient’s cohort. The
cause of death in all cases was infarct-related (cardio-
genic shock, asystole, cardiac tamponade, arrhythmias
and stent thrombosis).
Baseline characteristics of the hospital death group
and those of the control group are listed in Table 1.
The two groups were not significantly different regard-
ing risk factors and previous medical history. However,
the patients in the hospital death group were slightly,
but significantly (p¼ 0.0006) older as compared to con-
trols. Proportionally, significantly (p¼ 0.0361) more
TTECG-based consultations were carried out in the
control group as compared to the hospital death
group (Table 1).
The incidence of pre-hospital AHF and successful
resuscitation were – as expected – significantly higher
in the hospital death group compared to controls
(Table 1). The pre-hospital medical therapy is summar-
ised in Table 2. In the control group, significantly more
acetylsalicylic acid (ASA)/clopidogrel, sodium-heparin
(5000U bolus), low-dose nitroglycerin infusion and
upstream or downstream glycoprotein (GP) IIb/IIIa
inhibitor (eptifibatide) were used by the paramedics
or cardiologists. The majority of GP IIb/IIIa inhibitor
administration (>90%) was carried out downstream.
Nevertheless, in the hospital death group significantly
more atropine and intravenous inotropes were admin-
istered prior to hospital admission compared
to controls.
An examination of the coronary angiograms in
patients revealed that the total occlusion rate of the
infarct-related artery before PCI was significantly
higher in the hospital death group as compared to con-
trols (p¼ 0.0462, Table 2). This finding was in accor-
dance with the lower frequency of pre-hospital
Table 1. Baseline characteristics of patients.
Hospital death
group (n¼49)
Control
group (n¼726) p value
General
Age (years) 66.6112.09 60.6311.76 0.0006
Men (%) 65.30 67.21 0.7830
Anterior myocardial infarction (%) 53.06 46.20 0.3834
TTECG based consultation (%) 36.73 51.99 0.0361
AHF (Killip >2) (%) 30.61 4.41 <0.0001
Pre-hospital resuscitation (%) 32.65 5.23 <0.0001
Previous history (%)
Myocardial infarction 16.32 9.22 0.1041
Stroke 6.12 3.72 0.3989
Congestive heart failure 16.32 10.61 0.2152
PCI 10.20 7.71 0.5312
Previous cardiac risk factors (%)
Hypertension 69.38 67.58 0.7942
Diabetes mellitus 30.61 21.21 0.1232
Hypercholesterolaemia 44.89 55.64 0.1435
AHF: acute heart failure; ECG: electrocardiogram; PCI: percutaneous coronary intervention; SD: standard deviation;
TTECG: transtelephonic ECG.
Values are meansSD or percentages of subjects. Here, the p value refers to differences between the hospital death group and
the control group.
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antithrombotic medication used. Similar to the total
occlusion rate, the intracoronary thrombus rate
before PCI was slightly higher amongst hospital
deaths compared to controls (80.03% vs. 64.81%),
but the difference was statistically not significant. The
door-to-sheath and door-to-balloon insertion times
were significantly longer in the hospital death group
(Table 2). An examination of the TIMI flow before
PCI revealed no significant difference between the
two groups (Table 2).
All the predetermined parameters with significant
differences (p< 0.05) between groups were assessed
by the univariate log-rank test (Figure 1), and odds
ratios and CIs for in-hospital mortality were calculat-
ed. With the univariate statistical method, various
basic data, drug therapy specific parameters and PCI
procedural findings were found to have a significant
influence on the in-hospital mortality of STEMI
patients. Our data analysis showed that age, the pres-
ence of pre-hospital AHF, successful resuscitation,
door-to-sheath insertion time, door-to-balloon infla-
tion time and total occlusion of the infarct-related
artery before PCI were associated with significantly
increased odds ratios (Figure 1). At the same time,
the TTECG-based consultation and an adequate
pre-hospital medical therapy (sodium heparin, ASA
and/or clopidogrel, GP IIb/IIIa inhibitor and nitrate
infusion) significantly lowered the odds ratios of in-
hospital mortality (Figure 1).
Baseline characteristics and treatment related varia-
bles with a p< 0.05 in the univariate analysis were
selected for multiple regression and were quantified
for odds ratios and CIs for in-hospital mortality.
Interestingly, the TTECG-based consultation and
triage (odds ratio 0.48, CI 0.25–0.92, p¼ 0.0261)
proved to be a significant independent predictor of a
lower risk. Regarding pre-hospital medical therapy, the
administration of ASA and/or clopidogrel (odds ratio
0.36, CI 0.15–0.89, p¼ 0.0271) and GP IIb/IIIa inhib-
itor (odds ratio 0.49, CI 0.24–0.99, p¼ 0.0476) were the
most important independent predictors of a decreased
risk in this model. Despite this, age (odds ratio 2.33, CI
1.58–3.43, p¼ 0.0001), AHF (odds ratio 3.98, CI 1.55–
10.22, p¼ 0.0041) and successful pre-hospital resuscita-
tion (odds ratio 5.85, CI 2.28–15.04, p¼ 0.0002) were
the most important independent predictors of an
increased risk.
All the other parameters in question that were below
p< 0.05 in the univariate analysis (i.e. sodium heparin,
atropine, inotropes and nitrate infusion) were not
found to be significant independent predictors of in-
hospital mortality.
Table 2. Pre-hospital medical therapy and PCI procedural details of the study population.
Hospital death
group (n¼49)
Control
group (n¼726) p value
Pre-hospital medical therapy (%)
Acetylsalicylic acid and/or clopidogrel 65.91 91.41 <0.0001
Sodium heparin 69.38 81.40 0.0394
Nitroglycerin infusion 4.08 24.24 0.0012
Narcotics 44.89 47.10 0.7644
Atropine 20.41 5.92 <0.0001
Beta-blocker 8.1 4.9 0.2513
Intravenous inotropes 20.41 3.85 <0.0001
GP IIb/IIIa inhibitor 22.44 37.19 0.0379
PCI procedural parameters
Stent/patient (meanSD) 0.900.94 1.350.82 0.0002
Drug eluting stent (%) 4.08 4.54 0.8798
LADa (%) 53.06 50.54 0.7832
CXa (%) 20.40 19.55 0.8945
RCAa (%) 34.67 37.46 0.7930
Total occlusion before PCI (%) 73.33 54.75 0.0462
Intracoronary thrombus before PCI (%) 80.03 64.81 0.0883
TIMI flow before PCI 0.931.36 1.161.37 0.3049
Door to sheath insertion time (min) 55.8522.78 44.3117.20 0.0001
Door to balloon insertion time (min) 70.2026.01 61.1518.63 0.0039
CX: left circumflex; LAD: left anterior descending; PCI: percutaneous coronary intervention; RCA: right coronary artery; SD:
standard deviation.
The values are means SD or percentages of subjects. The p value denotes the differences between the hospital death group
and the control group.
aPatients may have had interventions on more than one vessel.
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Lastly, while examining the PCI procedural data
(total occlusion, door-to-sheath and door-to-balloon
insertion times), the most important independent pre-
dictor of in-hospital mortality was the total occlusion
of the infarct-related artery before PCI (odds ratio
5.92, CI 1.03–33.70, p¼ 0.0448).
Discussion
In a previous study we observed that, in a population
of STEMI patients, TTECG-based consultation with
cardiologists contributed to a significantly lower in-
hospital mortality rate.3 This finding was somewhat
unexpected, and it was hypothesised that the benefit
of the TTECG-based consultation was due to
improved pre-hospital medical therapy and conse-
quently enhanced coronary artery perfusion on hospi-
tal admission.3 Indeed, in the present study we have
shown that adequate pre-hospital medical therapy
(administration of ASA and/or clopidogrel, GP IIb/
IIIa inhibitor and sodium heparin) decreased: (a) the
total occlusion rate of the infarct-related artery and (b)
the risk of in-hospital mortality. Moreover, our find-
ings strongly suggest that the TTECG and the
TTECG-based adequate pre-hospital medical therapy
(administration of ASA and/or clopidogrel and GP
IIb/IIIa inhibitor) and the total occlusion of the
infarct-related artery before PCI are important inde-
pendent predictors for a lower in-hospital mortali-
ty rate.
It is generally accepted that total occlusions and
intracoronary thrombi are directly associated with
lower coronary flow, myocardial damage and loss of
function. Yet, better coronary flow translates into
improved myocardial protection and function and ulti-
mately, to an increased survival rate. Based on this
assumption, it was demonstrated in the Assessment of
the Safety and Efficacy of a New Treatment Strategy
with Percutaneous Coronary Intervention (ASSENT-4
PCI) trial that suboptimal antithrombotic pre-hospital
treatment (underuse of sodium-heparin) in STEMI
patients might lead to a higher mortality.5
Figure 1. Odds ratios and 95% confidence intervals for hospital mortality in the different subgroups, defined according to baseline
characteristics, pre-hospital medical therapy and percutaneous coronary intervention related procedural data. The size of each
symbol is proportional to the number of patients in each group. In the case of some parameters (door-to-sheath time and door-to-
balloon time and acetylsalicylic acid and/or clopidogrel), the confidence intervals are within the symbols.
AHF: acute heart failure; ASA/clopi: acetylsalicylic acid and/or clopidogrel; Door-to-sheath: door-to-sheath insertion time; Door-to-
balloon: door-to-balloon insertion time; GP IIb/IIIa: glycoprotein IIb/IIIa inhibitor; TTECG: transtelephonic electrocardiogram.
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In accordance with this finding, our current results
indicate that the underuse of pre-hospital sodium hep-
arin, ASA and/or clopidogrel and GP IIb/IIIa inhibitor
may have a major impact on coronary patency before
PCI. In the recent European Society of Cardiology
(ESC) guidelines on STEMI and on myocardial revas-
cularization, great emphasis is placed on early and
complete revascularization.1,6 If primary PCI cannot
be performed within 120 min after STEMI diagnosis,
fibrinolytic therapy is recommended, provided that
there are no contraindications (class IA recommenda-
tion).1 To reduce the time spent before treatment fibri-
nolysis was proposed even in the pre-hospital setting.1
Theoretically, the coronary perfusion and prevention
of intracoronary thrombi and occlusion are also equal-
ly important for STEMI patients undergoing primary
PCI. Consequently, the early and adequate pre-hospital
antithrombotic therapy prior to primary PCI should be
emphasised and supported.7–9 In the ESC/European
Association for Cardio-Thoracic Surgery (EACTS)
guideline on myocardial revascularization,6 the admin-
istration of ASA and/or clopidogrel and (upstream)
GP IIb/IIIa inhibitor prior to primary PCI are class I
and class IIb recommendations, respectively. The
downstream use of a GP IIb/IIIa inhibitor (‘in-lab’
use) for bailout or evidence of a thrombotic complica-
tion is a class IIa recommendation.
According to recent guidelines, upon suspected
STEMI a 12-lead ECG must be acquired and inter-
preted as soon as possible at the time of first medical
contact in order to facilitate an early diagnosis and
triage.1 For this purpose, the TTECG seems to be an
adequate tool. With the TTECG not only can the
recording be retrieved and stored, but there is also
the immediate possibility for a triage of patients. It
has been shown that the early pre-hospital triage with
telemedicine in subjects with STEMI undergoing pri-
mary PCI significantly reduces the time spent before
treatment,3,10 while improving pre-hospital manage-
ment.3,11 Pre-hospital TTECG triage has been shown
to associate with higher rates of timely reperfusion
both in patients close to the PCI laboratory and even
in rural areas.11
Moreover, the use of telemedicine in pre-hospital
triage of STEMI patients has been shown to be associ-
ated with lower mortality rates in both observational
studies3,12,13 and meta-analyses.10,14 The benefit seems
to be even larger in higher risk subjects.13,15 These
remarkable findings on mortality3,10,12–15 are probably
mediated by a reduced time-to-effective treatment (i.e.
the reduction of ischaemic time and necrotic area) and
better pre-hospital care consequent to pre-hospital
triage with telemedicine.16 In accordance with these
observations, the TTECG-based teleconsultation and
triage combination in our present study was found to
be an independent predictor of lower in-hospital mor-
tality rate.
In the present study, we demonstrated that the suc-
cessful pre-hospital resuscitation of STEMI patients
and AHF (Killip class> 2) are important independent
predictors of in-hospital death. These observations are
in line with those of previous reports.17,18 The resusci-
tation procedure itself explains why a significantly
higher amount of atropine and intravenous inotropes
in these patients (hospital death group) was used.
Moreover, the haemodynamic instability of these
patients following resuscitation usually contraindicates
the use of nitrates. This explains the lower nitrate use in
the hospital death group.
Conclusions
In summary, our findings indicate that a previously
published higher in-hospital survival rate of STEMI
patients elicited by TTECG-based teleconsultation3 is
associated with better coronary flow in response to
improved pre-hospital medical therapy. According to
our data: (a) an early, TTECG-facilitated diagnosis of
STEMI and a triage of patients, (b) optimal pre-
hospital antithrombotic therapy (administration of
ASA and/or clopidogrel and GP IIb/IIIa inhibitor)
and (c) the patency and better perfusion of the
infarct-related artery before PCI are important inde-
pendent predictors of a lower in-hospital mortality
rate (i.e. higher survival rate).
Limitations of the study
The limitation of our study is the fact that all data
analyses were carried out on a retrospective basis and
on a relatively small sample size (hospital death group;
n¼ 49). However, during data collection great efforts
were made to standardise the database: the two groups
(hospital death and control) were not significantly dif-
ferent regarding risk factors and previous medical his-
tory, a relatively long inclusion time (two years) was
used in the study and all STEMI patients were included
in the database.
Another limitation of our study is that treatment
effects were concluded through observational data.
There may have been other variables that were not
taken into consideration in our model.
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